BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1904403)

  • 1. Dopaminergic abnormalities in borderline essential hypertensive patients.
    Shigetomi S; Buu NT; Kuchel O
    Hypertension; 1991 Jun; 17(6 Pt 2):997-1002. PubMed ID: 1904403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective dopamine generation from dihydroxyphenylalanine in stable essential hypertensive patients.
    Kuchel O; Shigetomi S
    Hypertension; 1992 Jun; 19(6 Pt 2):634-8. PubMed ID: 1592460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic abnormalities in hypertension associated with moderate renal insufficiency.
    Kuchel OG; Shigetomi S
    Hypertension; 1994 Jan; 23(1 Suppl):I240-5. PubMed ID: 8282367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective 3,4-dihydroxyphenylalanine decarboxylation to dopamine in hydralazine-treated hypertensive patients may be pyridoxine remediable.
    Shigetomi S; Kuchel O
    Am J Hypertens; 1993 Jan; 6(1):33-40. PubMed ID: 8427659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential catecholamine responses to protein intake in healthy and hypertensive subjects.
    Kuchel O
    Am J Physiol; 1998 Oct; 275(4):R1164-73. PubMed ID: 9756547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model.
    Soares-da-Silva P; Pestana M; Vieira-Coelho MA; Fernandes MH; Albino-Teixeira A
    Br J Pharmacol; 1995 Apr; 114(7):1403-13. PubMed ID: 7541690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An increase in renal dopamine does not stimulate natriuresis after fava bean ingestion.
    Garland EM; Cesar TS; Lonce S; Ferguson MC; Robertson D
    Am J Clin Nutr; 2013 May; 97(5):1144-50. PubMed ID: 23553159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Borderline hypertensive autosomal dominant polycystic kidney disease patients have enhanced production of renal dopamine. Normalization of renal haemodynamics by DOPA infusion.
    Barendregt JN; Florijn KW; Muizert Y; Chang PC
    Nephrol Dial Transplant; 1995; 10(8):1332-41. PubMed ID: 8538923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High urinary dopa and low urinary dopamine-to-dopa ratio in salt-sensitive hypertension.
    Gill JR; Grossman E; Goldstein DS
    Hypertension; 1991 Nov; 18(5):614-21. PubMed ID: 1937664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High sodium intake increases the urinary excretion of L-3,4-dihydroxyphenylalanine but fails to alter the urinary excretion of dopamine and amine metabolites in Wistar rats.
    Vieira-Coelho MA; Pestana M; Soares-da-Silva P
    Gen Pharmacol; 1996 Dec; 27(8):1421-7. PubMed ID: 9304419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased urinary dopamine excretion in young patients with essential hypertension.
    Saito I; Itsuji S; Takeshita E; Kawabe H; Nishino M; Wainai H; Hasegawa C; Saruta T; Nagano S; Sekihara T
    Clin Exp Hypertens; 1994 Jan; 16(1):29-39. PubMed ID: 8136773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary dopamine and renal handling of L-DOPA in fasted spontaneously hypertensive rats.
    Dantonello TM; Küster E; Mühlbauer B
    Kidney Blood Press Res; 1998; 21(6):438-44. PubMed ID: 9933829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered dopaminergic responses in hypertension.
    Clark BA; Rosa RM; Epstein FH; Young JB; Landsberg L
    Hypertension; 1992 Jun; 19(6 Pt 1):589-94. PubMed ID: 1592453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart failure, aging, and renal synthesis of dopamine.
    Ferreira A; Bettencourt P; Pestana M; Correia F; Serrão P; Martins L; Cerqueira-Gomes M; Soares-Da-Silva P
    Am J Kidney Dis; 2001 Sep; 38(3):502-9. PubMed ID: 11532681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary excretion of dihydroxyphenylalanine and dopamine during alterations of dietary salt intake in humans.
    Goldstein DS; Stull R; Eisenhofer G; Gill JR
    Clin Sci (Lond); 1989 May; 76(5):517-22. PubMed ID: 2498027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivation of urinary dopamine from plasma dopa.
    Zimlichman R; Levinson PD; Kelly G; Stull R; Keiser HR; Goldstein DS
    Clin Sci (Lond); 1988 Nov; 75(5):515-20. PubMed ID: 3151165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated renal production of dopamine in patients with low renin essential hypertension.
    Aoki K; Kikuchi K; Yamaji I; Nishimura M; Honma C; Kobayakawa H; Yamamoto M; Kudoh C; Shimazaki M; Sakamoto T
    Clin Exp Hypertens A; 1989; 11 Suppl 1():403-9. PubMed ID: 2663252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study on the relationship between natriuresis and renally formed dopamine in the rat].
    Yamazaki N
    Nihon Yakurigaku Zasshi; 1990 Jul; 96(1):23-30. PubMed ID: 2210487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of water immersion on sympathoadrenal and dopa-dopamine systems in humans.
    Grossman E; Goldstein DS; Hoffman A; Wacks IR; Epstein M
    Am J Physiol; 1992 Jun; 262(6 Pt 2):R993-9. PubMed ID: 1535759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrarenal production of dopamine and natriuresis following DOPA and saline infusions in healthy human volunteers.
    Barendregt JN; Muizert Y; van Nispen tot Pannerden LL; Chang PC
    J Hum Hypertens; 1995 Mar; 9(3):187-94. PubMed ID: 7783100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.